JB Chemicals secures USFDA nod for generic version of Clartin tablet
Mumbai: Drug major, J.B. Chemicals & Pharmaceuticals Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use.This product is generic version...
Mumbai: Drug major, J.B. Chemicals & Pharmaceuticals Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use.
